Publications by Simen Myhre
16 publications found
Original articles
Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours
Health Qual Life Outcomes, 18 (1), 188
DOI 10.1186/s12955-020-01452-7, PubMed 32546236
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials
Acta Oncol, 57 (1), 38-43
DOI 10.1080/0284186X.2017.1401735, PubMed 29172851
Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort
Clin Cancer Res, 20 (20), 5272-80
DOI 10.1158/1078-0432.CCR-14-0458, PubMed 25149560
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer
Acta Oncol, 53 (10), 1337-46
DOI 10.3109/0284186X.2014.925580, PubMed 24957550
Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection
Virchows Arch, 463 (6), 775-86
DOI 10.1007/s00428-013-1486-1, PubMed 24100522
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
Mol Oncol, 7 (3), 704-18
DOI 10.1016/j.molonc.2013.02.018, PubMed 23562353
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
Clin Proteomics, 8 (1), 11
DOI 10.1186/1559-0275-8-11, PubMed 21906370
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Clin Proteomics, 6 (4), 129-51
DOI 10.1007/s12014-010-9055-y, PubMed 21691416
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome
PLoS One, 5 (11), e14002
DOI 10.1371/journal.pone.0014002, PubMed 21124964
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
Clin Cancer Res, 15 (11), 3654-62
DOI 10.1158/1078-0432.CCR-08-3293, PubMed 19470724
Changes in gene expression of gastric mucosa during therapeutic acid inhibition
Eur J Gastroenterol Hepatol, 20 (7), 613-23
DOI 10.1097/MEG.0b013e3282f5dc19, PubMed 18679062
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters
Mol Cancer, 5, 47
DOI 10.1186/1476-4598-5-47, PubMed 17054774
Additional gene ontology structure for improved biological reasoning
Bioinformatics, 22 (16), 2020-7
DOI 10.1093/bioinformatics/btl334, PubMed 16787968
Other articles
The importance of gene-centring microarray data
Lancet Oncol, 11 (8), 719-20; author reply 720-1
DOI 10.1016/S1470-2045(10)70174-1, PubMed 20688275
Theses
A molecular study of breast carcinomas in relation to patient outcome and tumor characteristics
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 1184, 1 b. (flere pag.)
BIBSYS 114631379, ISBN 978-82-8264-042-8
Utvikling av metode for annotering i "Gene ontology" anvendt på genprodukter fra mikroarraystudier av BON- og AR42J-celler
S. Myhre, [Trondheim], 264 s.
BIBSYS 031609740